170 related articles for article (PubMed ID: 18435429)
1. Globally optimal trial design for local decision making.
Eckermann S; Willan AR
Health Econ; 2009 Feb; 18(2):203-16. PubMed ID: 18435429
[TBL] [Abstract][Full Text] [Related]
2. Expected value of information and decision making in HTA.
Eckermann S; Willan AR
Health Econ; 2007 Feb; 16(2):195-209. PubMed ID: 16981193
[TBL] [Abstract][Full Text] [Related]
3. Accounting for between-study variation in incremental net benefit in value of information methodology.
Willan AR; Eckermann S
Health Econ; 2012 Oct; 21(10):1183-95. PubMed ID: 21882285
[TBL] [Abstract][Full Text] [Related]
4. Time and expected value of sample information wait for no patient.
Eckermann S; Willan AR
Value Health; 2008; 11(3):522-6. PubMed ID: 18179665
[TBL] [Abstract][Full Text] [Related]
5. Determining optimal sample sizes for multistage adaptive randomized clinical trials from an industry perspective using value of information methods.
Chen MH; Willan AR
Clin Trials; 2013 Feb; 10(1):54-62. PubMed ID: 23263520
[TBL] [Abstract][Full Text] [Related]
6. The value of value of information: best informing research design and prioritization using current methods.
Eckermann S; Karnon J; Willan AR
Pharmacoeconomics; 2010; 28(9):699-709. PubMed ID: 20629473
[TBL] [Abstract][Full Text] [Related]
7. Optimal global value of information trials: better aligning manufacturer and decision maker interests and enabling feasible risk sharing.
Eckermann S; Willan AR
Pharmacoeconomics; 2013 May; 31(5):393-401. PubMed ID: 23529209
[TBL] [Abstract][Full Text] [Related]
8. Determining optimal sample sizes for multi-stage randomized clinical trials using value of information methods.
Willan A; Kowgier M
Clin Trials; 2008; 5(4):289-300. PubMed ID: 18697843
[TBL] [Abstract][Full Text] [Related]
9. Optimal sample size determinations from an industry perspective based on the expected value of information.
Willan AR
Clin Trials; 2008; 5(6):587-94. PubMed ID: 19029207
[TBL] [Abstract][Full Text] [Related]
10. Revolution then evolution: the advance of health economic evaluation in Australia.
Lopert R; Viney R
Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):360-6. PubMed ID: 25444293
[TBL] [Abstract][Full Text] [Related]
11. Value of research and value of development in early assessments of new medical technologies.
Retèl VP; Grutters JP; van Harten WH; Joore MA
Value Health; 2013; 16(5):720-8. PubMed ID: 23947964
[TBL] [Abstract][Full Text] [Related]
12. Value of information analyses of economic randomized controlled trials: the treatment of intermittent claudication.
Groot Koerkamp B; Spronk S; Stijnen T; Hunink MG
Value Health; 2010; 13(2):242-50. PubMed ID: 19818058
[TBL] [Abstract][Full Text] [Related]
13. Value of information analysis optimizing future trial design from a pilot study on catheter securement devices.
Tuffaha HW; Reynolds H; Gordon LG; Rickard CM; Scuffham PA
Clin Trials; 2014 Dec; 11(6):648-56. PubMed ID: 25084784
[TBL] [Abstract][Full Text] [Related]
14. A reinvestigation of recruitment to randomised, controlled, multicenter trials: a review of trials funded by two UK funding agencies.
Sully BG; Julious SA; Nicholl J
Trials; 2013 Jun; 14():166. PubMed ID: 23758961
[TBL] [Abstract][Full Text] [Related]
15. Estimating the marginal value of 'better' research output: 'designed' versus 'routine' data in randomised controlled trials.
Cohen D; Longo MF; Williams J; Cheung WY; Hutchings H; Russell IT
Health Econ; 2003 Nov; 12(11):959-74. PubMed ID: 14601158
[TBL] [Abstract][Full Text] [Related]
16. The option value of delay in health technology assessment.
Eckermann S; Willan AR
Med Decis Making; 2008; 28(3):300-5. PubMed ID: 18480035
[TBL] [Abstract][Full Text] [Related]
17. Prioritizing investments in health technology assessment. Can we assess potential value for money?
Davies L; Drummond M; Papanikolaou P
Int J Technol Assess Health Care; 2000; 16(1):73-91. PubMed ID: 10815355
[TBL] [Abstract][Full Text] [Related]
18. Diffusion and use of health technology assessment in policy making: what lessons for decentralised healthcare systems?
Ciani O; Tarricone R; Torbica A
Health Policy; 2012 Dec; 108(2-3):194-202. PubMed ID: 23093020
[TBL] [Abstract][Full Text] [Related]
19. Health technology assessment in its local contexts: studies of telehealthcare.
May C; Mort M; Williams T; Mair F; Gask L
Soc Sci Med; 2003 Aug; 57(4):697-710. PubMed ID: 12821017
[TBL] [Abstract][Full Text] [Related]
20. Efficient design of cluster randomized and multicentre trials with unknown intraclass correlation.
van Breukelen GJ; Candel MJ
Stat Methods Med Res; 2015 Oct; 24(5):540-56. PubMed ID: 21937473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
